{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T23:03:55Z","timestamp":1790982235992,"version":"4.1.0"},"reference-count":377,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/j.pharmthera.2020.107578","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T14:11:48Z","timestamp":1589551908000},"page":"107578","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"special_numbering":"C","title":["Modeling epileptic spasms during infancy: Are we heading for the treatment yet?"],"prefix":"10.1016","volume":"212","author":[{"given":"Libor","family":"Vel\u00ed\u0161ek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Vel\u00ed\u0161kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pharmthera.2020.107578_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1677\/joe.0.1080171","article-title":"Corticotrophin-releasing factor-like immunoreactivity and bioactivity of human fetal and adult hypothalami","volume":"108","author":"Ackland","year":"1986","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0010","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1054\/tice.2002.0217","article-title":"GABA in the endocrine pancreas: Cellular localization and function in normal and diabetic rats","volume":"34","author":"Adeghate","year":"2002","journal-title":"Tissue & Cell"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0015","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1002\/acn3.50998","article-title":"Radiprodil, a NR2B negative allosteric modulator, from bench to bedside in infantile spasm syndrome","volume":"7","author":"Auvin","year":"2020","journal-title":"Annals of Clinical Translational Neurology"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2020.107578_bb0020","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/epi.13782","article-title":"Prospective clinical trials to investigate clinical and molecular biomarkers","volume":"58","author":"Auvin","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0025","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/S0166-2236(02)02241-5","article-title":"Stressed-out, or in (utero)?","volume":"25","author":"Avishai-Eliner","year":"2002","journal-title":"Trends in Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0030","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.neuint.2016.05.006","article-title":"Altered expression of KCC2 in GABAergic interneuron contributes prenatal stress-induced epileptic spasms in infant rat","volume":"97","author":"Baek","year":"2016","journal-title":"Neurochemistry International"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0035","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/0165-3806(84)90149-4","article-title":"Loss of intrinsic striatal neurons after methylazoxymethanol acetate treatment in pregnant rats","volume":"317","author":"Balduini","year":"1984","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0040","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0920-1211(95)00094-1","article-title":"Flurothyl seizure susceptibility in rats following prenatal methylazoxymethanol treatment","volume":"23","author":"Baraban","year":"1996","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0045","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ana.410330302","article-title":"Pathophysiology of massive infantile spasms: Perspective on the putative role of the brain adrenal axis","volume":"33","author":"Baram","year":"1993","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0050","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1002\/ana.410310505","article-title":"Corticotropin-releasing hormone-induced seizures in infant rats originate in the amygdala","volume":"31","author":"Baram","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0055","first-page":"320","article-title":"Inhibition of pituitary-adrenal secretion by a corticotropin releasing hormone antagonist in humans","volume":"1","author":"Baram","year":"1996","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0060","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/0887-8994(95)00121-U","article-title":"Cerebrospinal fluid corticotropin and cortisol are reduced in infantile spasms","volume":"13","author":"Baram","year":"1995","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0065","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1212\/WNL.42.6.1171","article-title":"Brain-adrenal axis hormones are altered in the CSF of infants with massive infantile spasms","volume":"42","author":"Baram","year":"1992","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0070","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1542\/peds.97.3.375","article-title":"High-dose corticotropin (ACTH) versus prednisone for infantile spasms: A prospective, randomized, blinded study","volume":"97","author":"Baram","year":"1996","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0075","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0165-3806(91)90118-3","article-title":"Corticotropin-releasing hormone is a rapid and potent convulsant in the infant rat","volume":"61","author":"Baram","year":"1991","journal-title":"Developmental Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0080","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/j.1528-1157.1995.tb00977.x","article-title":"ACTH does not control neonatal seizures induced by administration of exogenous corticotropin-releasing hormone","volume":"36","author":"Baram","year":"1995","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0085","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.seizure.2016.12.016","article-title":"Diagnosis, treatment, and outcomes of infantile spasms in the trisomy 21 population","volume":"45","author":"Beatty","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0090","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2045-5380-1-9","article-title":"Criteria of validity for animal models of psychiatric disorders: Focus on anxiety disorders and depression","volume":"1","author":"Belzung","year":"2011","journal-title":"Biology of Mood & Anxiety Disorders"},{"key":"10.1016\/j.pharmthera.2020.107578_bb4045","doi-asserted-by":"crossref","first-page":"106276","DOI":"10.1016\/j.eplepsyres.2020.106276","article-title":"Prenatal betamethasone exposure increases corticotropin-releasing hormone expression along with increased hippocampal slice excitability in the developing hippocampus","volume":"160","author":"Benson","year":"2020","journal-title":"Epilepsy Res"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0095","doi-asserted-by":"crossref","first-page":"15894","DOI":"10.1523\/JNEUROSCI.2803-15.2015","article-title":"Maternal stress combined with terbutaline leads to comorbid autistic-like behavior and epilepsy in a rat model","volume":"35","author":"Bercum","year":"2015","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0100","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1528-1167.2010.02522.x","article-title":"Revised terminology and concepts for organization of seizures and epilepsies: Report of the ILAE Commission on Classification and Terminology, 2005\u20132009","volume":"51","author":"Berg","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0105","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0193599","article-title":"Why West? Comparisons of clinical, genetic and molecular features of infants with and without spasms","volume":"13","author":"Berg","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0110","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.yebeh.2019.05.011","article-title":"Immediate outcomes in early life epilepsy: A contemporary account","volume":"97","author":"Berg","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0115","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.braindev.2016.02.002","article-title":"17q21.31 microdeletion syndrome: Description of a case further contributing to the delineation of Koolen-de Vries syndrome","volume":"38","author":"Bernardo","year":"2016","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0120","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/cge.12034","article-title":"Early-onset epileptic encephalopathy in a girl carrying a truncating mutation of the ARX gene: Rethinking the ARX phenotype in females","volume":"84","author":"Bettella","year":"2013","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0125","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1055\/s-2008-1052491","article-title":"High dose B6 treatment in infantile spasms","volume":"17","author":"Blennow","year":"1986","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0130","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/epi.13034","article-title":"The GIRK2 subunit is involved in IS-like seizures induced by GABA(B) receptor agonists","volume":"56","author":"Blichowski","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0135","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1684\/epd.2009.0261","article-title":"Malformations of cortical development and epilepsies: Neuropathological findings with emphasis on focal cortical dysplasia","volume":"11","author":"Blumcke","year":"2009","journal-title":"Epileptic Disorders"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0140","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0165-3806(94)90192-9","article-title":"Development of mRNAs for glucocorticoid and mineralocorticoid receptors in rat hippocampus","volume":"77","author":"Bohn","year":"1994","journal-title":"Brain Research. Developmental Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0145","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/STROKEAHA.117.017112","article-title":"Translational stroke research: Vision and opportunities","volume":"48","author":"Bosetti","year":"2017","journal-title":"Stroke"},{"issue":"Suppl. 4","key":"10.1016\/j.pharmthera.2020.107578_bb0150","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/epi.12567","article-title":"Lennox-Gastaut syndrome: A consensus approach to differential diagnosis","volume":"55","author":"Bourgeois","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ejmg.2014.11.007","article-title":"Molecular characterization of a cohort of 73 patients with infantile spasms syndrome","volume":"58","author":"Boutry-Kryza","year":"2015","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0160","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0165-3806(87)90104-0","article-title":"Human corticoliberin hypothalamic neuroglandular system: Comparative immunocytochemical study with anti-rat and anti-ovine corticotropin-releasing factor sera in the early stages of development","volume":"429","author":"Bresson","year":"1987","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0165","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/epi.12424","article-title":"CPP-115, a vigabatrin analogue, decreases spasms in the multiple-hit rat model of infantile spasms","volume":"55","author":"Briggs","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0170","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/S0074-7742(02)49013-7","article-title":"ACTH treatment of infantile spasms: Mechanisms of its effects in modulation of neuronal excitability","volume":"49","author":"Brunson","year":"2002","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0175","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/S0387-7604(01)00312-6","article-title":"How do the many etiologies of West syndrome lead to excitability and seizures? The corticotropin releasing hormone excess hypothesis","volume":"23","author":"Brunson","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0180","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1002\/ana.66","article-title":"Corticotropin (ACTH) acts directly on amygdala neurons to down-regulate corticotropin-releasing hormone gene expression","volume":"49","author":"Brunson","year":"2001","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0185","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/298159a0","article-title":"Ontogeny of the corticoliberin neuroglandular system in rat brain","volume":"298","author":"Bugnon","year":"1982","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0190","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S1474-4422(13)70265-5","article-title":"The genetic basis of DOORS syndrome: An exome-sequencing study","volume":"13","author":"Campeau","year":"2014","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0195","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1111\/j.1528-1167.2008.01589.x","article-title":"Vigabatrin in the treatment of childhood epilepsy: A retrospective chart review of efficacy and safety profile","volume":"49","author":"Camposano","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0200","doi-asserted-by":"crossref","first-page":"3026","DOI":"10.1002\/ajmg.a.35567","article-title":"Seizure characteristics in Pallister-Killian syndrome","volume":"158A","author":"Candee","year":"2012","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0205","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1111\/cge.13537","article-title":"Phenotypic spectrum of NRXN1 mono- and bi-allelic deficiency: A systematic review","volume":"97","author":"Castronovo","year":"2020","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0210","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/0165-3806(89)90120-X","article-title":"Methylazoxymethanol-induced microencephaly: Persistant increase of cortical somatostatin-like immunoreactivity","volume":"47","author":"Cattabeni","year":"1989","journal-title":"Developmental Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0215","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/epi.13434","article-title":"Estradiol does not affect spasms in the betamethasone-NMDA rat model of infantile spasms","volume":"57","author":"Chachua","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0220","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1111\/gbb.12160","article-title":"Sex-specific behavioral traits in the Brd2 mouse model of juvenile myoclonic epilepsy","volume":"13","author":"Chachua","year":"2014","journal-title":"Genes, Brain, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0225","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1111\/j.1528-1167.2012.03674.x","article-title":"Rapamycin has age-, treatment paradigm-, and model-specific anticonvulsant effects and modulates neuropeptide Y expression in rats","volume":"53","author":"Chachua","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0230","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1111\/j.1528-1167.2011.03220.x","article-title":"Validation of the rat model of cryptogenic infantile spasms","volume":"52","author":"Chachua","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0235","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/j.1471-4159.1973.tb06000.x","article-title":"Cerebellar development in the rat after postnatal damage by methylazoxymethanol: DNA, RNA and protein during recovery","volume":"21","author":"Chanda","year":"1973","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0240","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1038\/s41591-019-0608-y","article-title":"Therapeutic inhibition of mTORC2 rescues the behavioral and neurophysiological abnormalities associated with Pten-deficiency","volume":"25","author":"Chen","year":"2019","journal-title":"Nature Medicine"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0245","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2147\/NDT.S142032","article-title":"Genetic and epigenetic mechanisms of epilepsy: A review","volume":"13","author":"Chen","year":"2017","journal-title":"Neuropsychiatric Disease and Treatment"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0250","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.eplepsyres.2019.03.004","article-title":"AQB-565 shows promise in preclinical testing in the model of epileptic spasms during infancy: Head-to-head comparison with ACTH","volume":"152","author":"Chern","year":"2019","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0255","doi-asserted-by":"crossref","first-page":"106950","DOI":"10.1016\/j.yebeh.2020.106950","article-title":"ACTON PROLONGATUM(R) suppresses spasms head to head with Acthar(R) gel in the model of infantile spasms","volume":"105","author":"Chern","year":"2020","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0260","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S0006-8993(98)00932-9","article-title":"Decreased seizure threshold and more rapid rate of kindling in rats with cortical malformation induced by prenatal treatment with methylazoxymethanol","volume":"812","author":"Chevassus-au-Louis","year":"1998","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0265","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1159\/000017388","article-title":"Abnormal connections in the malformed cortex of rats with prenatal treatment with methylazoxymethanol may support hyperexcitability","volume":"21","author":"Chevassus-au-Louis","year":"1999","journal-title":"Developmental Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0270","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1002\/(SICI)1096-9861(19980518)394:4<520::AID-CNE9>3.0.CO;2-3","article-title":"Neocortex in the hippocampus: An anatomical and functional study of CA1 heterotopias after prenatal treatment with methylazoxymethanol in rats","volume":"394","author":"Chevassus-au-Louis","year":"1998","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0275","series-title":"American Epilepsy Society Annual Meeting (pp. 1.119). New Orleans, LA","article-title":"Effectiveness of the ketogenic diet for the control of seizures in the triple-hit model of the infantile spasms syndrome","author":"Choudhary","year":"2018"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0280","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/ana.410310212","article-title":"Infantile spasms: II. Lenticular nuclei and brain stem activation on positron emission tomography","volume":"31","author":"Chugani","year":"1992","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0285","doi-asserted-by":"crossref","first-page":"10674","DOI":"10.1523\/JNEUROSCI.1283-08.2008","article-title":"Arx is a direct target of Dlx2 and thereby contributes to the tangential migration of GABAergic interneurons","volume":"28","author":"Colasante","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0290","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1212\/WNL.21.9.911","article-title":"Infantile spasms associated with 5-hydroxytryptophan administration in patients with Down's syndrome","volume":"21","author":"Coleman","year":"1971","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0295","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1172\/JCI29115","article-title":"Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression","volume":"117","author":"Collombat","year":"2007","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0300","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/nature12439","article-title":"De novo mutations in epileptic encephalopathies","volume":"501","author":"Consortium","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0305","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.pediatrneurol.2010.04.010","article-title":"Simultaneous onset of infantile spasms in monozygotic twins","volume":"43","author":"Coppola","year":"2010","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0310","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1203\/PDR.0b013e31819d9076","article-title":"Infantile spasms and down syndrome: A new animal model","volume":"65","author":"Cortez","year":"2009","journal-title":"Pediatric Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0315","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.ejpn.2012.05.004","article-title":"Management of epilepsy associated with tuberous sclerosis complex (TSC): Clinical recommendations","volume":"16","author":"Curatolo","year":"2012","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0320","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s40261-017-0595-z","article-title":"West syndrome: A review and guide for paediatricians","volume":"38","author":"D'Alonzo","year":"2018","journal-title":"Clinical Drug Investigation"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0325","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/adc.2009.160606","article-title":"Developmental and epilepsy outcomes at age 4 years in the UKISS trial comparing hormonal treatments to vigabatrin for infantile spasms: A multi-centre randomised trial","volume":"95","author":"Darke","year":"2010","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0330","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1111\/epi.16284","article-title":"Increased electroencephalography connectivity precedes epileptic spasm onset in infants with tuberous sclerosis complex","volume":"60","author":"Davis","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0335","series-title":"American Epilepsy Society Annual Meeting (pp. 1.012). Washington, DC","article-title":"Transcriptional profiling of adult parvalbumin interneurons in a conditional knock-out model of Arx","author":"von Deimling","year":"2017"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0340","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1111\/epi.13937","article-title":"The impact of hypsarrhythmia on infantile spasms treatment response: Observational cohort study from the National Infantile Spasms Consortium","volume":"58","author":"Demarest","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0345","series-title":"Handbook of behavioral neuroscience","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/B978-0-12-800981-9.00008-0","article-title":"Dysregulation of dopamine systems in a developmental disruption model of schizophrenia: Implications for pathophysiology, treatment, and prevention","volume":"Vol. 23","author":"Dibble","year":"2016"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0350","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/cge.12636","article-title":"Whole-exome sequencing improves the diagnosis yield in sporadic infantile spasm syndrome","volume":"89","author":"Dimassi","year":"2016","journal-title":"Clinical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0355","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161660","article-title":"Thirty years of orphan drug legislation and the development of drugs to treat rare seizure conditions: A cross sectional analysis","volume":"11","author":"Doring","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0360","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/j.1528-1167.2010.02564.x","article-title":"Vigabatrin-associated reversible MRI signal changes in patients with infantile spasms","volume":"51","author":"Dracopoulos","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0365","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1111\/epi.14679","article-title":"Efficacy and tolerability of the ketogenic diet versus high-dose adrenocorticotropic hormone for infantile spasms: A single-center parallel-cohort randomized controlled trial","volume":"60","author":"Dressler","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0370","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1111\/j.1528-1157.1993.tb00454.x","article-title":"Genetic predisposition to West syndrome","volume":"34","author":"Dulac","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0375","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/0028-3908(83)90133-8","article-title":"Convulsant activity of pyridoxal sulphate and phosphonoethyl pyridoxal: Antagonism by GABA and its synthetic analogues","volume":"22","author":"Ebadi","year":"1983","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0380","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1111\/epi.12050","article-title":"West syndrome caused by ST3Gal-III deficiency","volume":"54","author":"Edvardson","year":"2013","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0385","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1006\/exnr.2002.7874","article-title":"The effects of ACTH and adrenocorticosteroids on seizure susceptibility in 15-day-old male rats","volume":"175","author":"Edwards","year":"2002","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0390","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/0006-8993(83)90266-4","article-title":"Corticotropin releasing factor produces increases in brain excitability and convulsive seizures in rats","volume":"278","author":"Ehlers","year":"1983","journal-title":"Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0395","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.braindev.2006.03.011","article-title":"Ketogenic diet for treatment of infantile spasms","volume":"28","author":"Eun","year":"2006","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0400","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.ajhg.2014.08.013","article-title":"De novo mutations in synaptic transmission genes including DNM1 cause epileptic encephalopathies","volume":"95","author":"EuroEPINOMICS-RES Consortium","year":"2014","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0405","doi-asserted-by":"crossref","first-page":"302","DOI":"10.4103\/JPN.JPN_182_17","article-title":"Electroclinical pattern and epilepsy evolution in an infant with Miller-Dieker syndrome","volume":"13","author":"Falsaperla","year":"2018","journal-title":"Journal of Pediatric Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0410","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/j.1528-1157.1984.tb03469.x","article-title":"Adrenocorticotropic hormone controls infantile spasms independently of cortisol stimulation","volume":"25","author":"Farwell","year":"1984","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0415","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.4103\/1673-5374.241442","article-title":"Ketogenic diet versus ketoacidosis: What determines the influence of ketone bodies on neurons?","volume":"13","author":"Fedorovich","year":"2018","journal-title":"Neural Regeneration Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0420","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/1043-6618(95)80055-7","article-title":"Seizure susceptibility in immature rats with micrencephaly induced by prenatal exposure to methylazoxymethanol acetate","volume":"31","author":"de Feo","year":"1995","journal-title":"Pharmacological Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0425","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.spen.2017.03.017","article-title":"Hypothalamic hamartoma with infantile spasms: Case report with surgical treatment","volume":"26","author":"Fox","year":"2018","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0430","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.neuropharm.2011.04.018","article-title":"Carisbamate has powerful disease-modifying effects in the lithium-pilocarpine model of temporal lobe epilepsy","volume":"61","author":"Francois","year":"2011","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0435","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1212\/CPJ.0000000000000514","article-title":"Everolimus for treatment-refractory seizures in TSC: Extension of a randomized controlled trial","volume":"8","author":"Franz","year":"2018","journal-title":"Neurology Clinical Practice"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0440","doi-asserted-by":"crossref","first-page":"2153","DOI":"10.1016\/S0140-6736(16)31419-2","article-title":"Adjunctive everolimus therapy for treatment-resistant focal-onset seizures associated with tuberous sclerosis (EXIST-3): A phase 3, randomised, double-blind, placebo-controlled study","volume":"388","author":"French","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0445","doi-asserted-by":"crossref","first-page":"28","DOI":"10.3389\/fncel.2011.00028","article-title":"Identification of Arx targets unveils new candidates for controlling cortical interneuron migration and differentiation","volume":"5","author":"Friocourt","year":"2011","journal-title":"Frontiers in Cellular Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0450","series-title":"Infantile spasms: diagnosis, management and prognosis","author":"Frost","year":"2003"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0455","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/01.WNP.0000149893.12678.44","article-title":"Pathogenesis of infantile spasms: A model based on developmental desynchronization","volume":"22","author":"Frost","year":"2005","journal-title":"Journal of Clinical Neurophysiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0460","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nbd.2015.04.019","article-title":"Vigabatrin therapy implicates neocortical high frequency oscillations in an animal model of infantile spasms","volume":"82","author":"Frost","year":"2015","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0465","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1528-1167.2010.02887.x","article-title":"High frequency EEG activity associated with ictal events in an animal model of infantile spasms","volume":"52","author":"Frost","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0470","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.nbd.2012.02.001","article-title":"Interictal high frequency oscillations in an animal model of infantile spasms","volume":"46","author":"Frost","year":"2012","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0475","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1038\/ejhg.2009.139","article-title":"Ohtahara syndrome in a family with an ARX protein truncation mutation (c.81C>G\/p.Y27X)","volume":"18","author":"Fullston","year":"2010","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0480","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1007\/s11064-017-2282-0","article-title":"Preclinical screening for treatments for infantile spasms in the multiple hit rat model of infantile spasms: An update","volume":"42","author":"Galanopoulou","year":"2017","journal-title":"Neurochemical Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0485","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1046\/j.1460-9568.2003.02920.x","article-title":"Postsynaptic contributions to hippocampal network hyperexcitability induced by chronic activity blockade in vivo","volume":"18","author":"Galvan","year":"2003","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0490","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/epi.13325","article-title":"Epilepsy in young Tsc1(+\/\u2212) mice exhibits age-dependent expression that mimics that of human tuberous sclerosis complex","volume":"57","author":"Gataullina","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0495","first-page":"21","article-title":"Do migrational disorders lower the seizure susceptibility in the immature rat brain?","volume":"34","author":"Germano","year":"1993","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0500","first-page":"250","article-title":"H.P. Acthar Gel and Cosyntropin review: Clinical and financial implications","volume":"34","author":"Gettig","year":"2009","journal-title":"P&T"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0505","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1542\/peds.13.1.66","article-title":"Diagnosis and prognosis of hypsarhythmia and infantile spasms","volume":"13","author":"Gibbs","year":"1954","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0510","series-title":"Atlas of electroencephalography","author":"Gibbs","year":"1952"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0515","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.pediatrneurol.2014.04.028","article-title":"Early neurodevelopmental screening in tuberous sclerosis complex: A potential window of opportunity","volume":"51","author":"Gipson","year":"2014","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0520","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1212\/WNL.0b013e318259e2cf","article-title":"Evidence-based guideline update: Medical treatment of infantile spasms. Report of the Guideline Development Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society","volume":"78","author":"Go","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0525","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0387-7604(01)00239-X","article-title":"Seizure frequency and characteristics in children with Down syndrome","volume":"23","author":"Goldberg-Stern","year":"2001","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0530","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/(SICI)1096-9861(19970728)384:2<165::AID-CNE1>3.0.CO;2-#","article-title":"Axonal remodeling during postnatal maturation of CA3 hippocampal pyramidal neurons","volume":"384","author":"Gomez-Di Cesare","year":"1997","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0535","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.pediatrneurol.2018.06.011","article-title":"Treating infantile spasms with high-dose oral corticosteroids: A retrospective review of 87 children","volume":"87","author":"Gonzalez-Giraldo","year":"2018","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0540","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1172\/JCI25091","article-title":"In humans, early cortisol biosynthesis provides a mechanism to safeguard female sexual development","volume":"116","author":"Goto","year":"2006","journal-title":"The Journal of Clinical Investigation"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0545","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1159\/000241012","article-title":"Rodent brain growth stages: An analytical review","volume":"32","author":"Gottlieb","year":"1977","journal-title":"Biology of the Neonate"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0550","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s12098-018-2782-1","article-title":"Corticotrophin-ACTH in comparison to prednisolone in West syndrome - A randomized study","volume":"86","author":"Gowda","year":"2019","journal-title":"Indian Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0555","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.seizure.2015.01.001","article-title":"Long-term outcomes in patients with West syndrome: An outpatient clinical study","volume":"25","author":"Guveli","year":"2015","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0560","first-page":"1520","article-title":"Comparison of effects of methylazoxymethanol acetate on brain development in different species","volume":"31","author":"Haddad","year":"1972","journal-title":"Federation Proceedings"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0565","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.yebeh.2019.03.040","article-title":"Clobazam as an adjunctive treatment for infantile spasms","volume":"95","author":"Hahn","year":"2019","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0570","first-page":"e12674","article-title":"Prenatal programming of stress responsiveness and behaviours: Progress and perspectives","author":"Hamada","year":"2018","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0575","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.braindev.2018.04.006","article-title":"Treatment of infantile spasms by pediatric neurologists in Japan","volume":"40","author":"Hamano","year":"2018","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0580","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.ejmg.2017.07.014","article-title":"Exome sequence identified a c.320A > G ALG13 variant in a female with infantile epileptic encephalopathy with normal glycosylation and random X inactivation: Review of the literature","volume":"60","author":"Hamici","year":"2017","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0585","first-page":"CD001770","article-title":"Treatment of infantile spasms","author":"Hancock","year":"2013","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0590","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.spen.2016.06.001","article-title":"Current and emerging therapies of severe epileptic encephalopathies","volume":"23","author":"Hani","year":"2016","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0595","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ajhg.2015.02.013","article-title":"De novo mutations in SIK1 cause a spectrum of developmental epilepsies","volume":"96","author":"Hansen","year":"2015","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0600","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0387-7604(81)80005-8","article-title":"Apparent brain atrophy and subdural hematoma following ACTH therapy","volume":"3","author":"Hara","year":"1981","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0605","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1016\/j.yhbeh.2010.06.007","article-title":"Glucocorticoids, prenatal stress and the programming of disease","volume":"59","author":"Harris","year":"2011","journal-title":"Hormones and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0610","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0387-7604(97)00026-0","article-title":"CSF ACTH and beta-endorphin in infants with West syndrome and ACTH therapy","volume":"19","author":"Heiskala","year":"1997","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0615","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/s41467-020-14360-7","article-title":"Loss-of-function mutations in UDP-Glucose 6-Dehydrogenase cause recessive developmental epileptic encephalopathy","volume":"11","author":"Hengel","year":"2020","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0620","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00439-015-1553-6","article-title":"Genomic analysis identifies candidate pathogenic variants in 9 of 18 patients with unexplained West syndrome","volume":"134","author":"Hino-Fukuyo","year":"2015","journal-title":"Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0625","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.braindev.2014.01.015","article-title":"Ketogenic diet therapy can improve ACTH-resistant West syndrome in Japan","volume":"37","author":"Hirano","year":"2015","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0630","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/ana.410200114","article-title":"Effects of ACTH on seizure susceptibility in the developing brain","volume":"20","author":"Holmes","year":"1986","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0635","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1111\/j.1528-1167.2010.02586.x","article-title":"Infantile spasms treated with the ketogenic diet: Prospective single-center experience in 104 consecutive infants","volume":"51","author":"Hong","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0640","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1126\/science.1321503","article-title":"The role of GABAB receptor activation in absence seizures of lethargic (lh\/lh) mice","volume":"257","author":"Hosford","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0645","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1212\/WNL.0000000000001926","article-title":"SCN2A encephalopathy: A major cause of epilepsy of infancy with migrating focal seizures","volume":"85","author":"Howell","year":"2015","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0650","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/epi4.12264","article-title":"Treatment of infantile spasms","volume":"3","author":"Hussain","year":"2018","journal-title":"Epilepsia Open"},{"issue":"215\u2013221","key":"10.1016\/j.pharmthera.2020.107578_bb0655","article-title":"Recognition of infantile spasms is often delayed: The ASSIST study","volume":"190","author":"Hussain","year":"2017","journal-title":"The Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0660","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2018.09.016","article-title":"High vigabatrin dosage is associated with lower risk of infantile spasms relapse among children with tuberous sclerosis complex","volume":"148","author":"Hussain","year":"2018","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0665","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.seizure.2016.01.002","article-title":"Limited efficacy of the ketogenic diet in the treatment of highly refractory epileptic spasms","volume":"35","author":"Hussain","year":"2016","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0670","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1111\/epi.12460","article-title":"Treatment of infantile spasms with very high dose prednisolone before high dose adrenocorticotropic hormone","volume":"55","author":"Hussain","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0675","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/epi.13712","article-title":"Risk of vigabatrin-associated brain abnormalities on MRI in the treatment of infantile spasms is dose-dependent","volume":"58","author":"Hussain","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0680","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yebeh.2015.04.009","article-title":"Perceived efficacy of cannabidiol-enriched cannabis extracts for treatment of pediatric epilepsy: A potential role for infantile spasms and Lennox-Gastaut syndrome","volume":"47","author":"Hussain","year":"2015","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0685","doi-asserted-by":"crossref","first-page":"5722","DOI":"10.1038\/s41598-018-24013-x","article-title":"ACTH and PMX53 recover synaptic transcriptome alterations in a rat model of infantile spasms","volume":"8","author":"Iacobas","year":"2018","journal-title":"Scientific Reports"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0690","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/jne.12061","article-title":"Prenatal corticosteroids modify glutamatergic and GABAergic synapse genomic fabric: Insights from a novel animal model of infantile spasms","volume":"25","author":"Iacobas","year":"2013","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0695","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1523\/JNEUROSCI.08-11-04151.1988","article-title":"The ontogeny of brain receptors for corticotropin-releasing factor and the development of their functional association with adenylate cyclase","volume":"8","author":"Insel","year":"1988","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0700","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1136\/jmedgenet-2016-104083","article-title":"A de novo missense mutation of GABRB2 causes early myoclonic encephalopathy","volume":"54","author":"Ishii","year":"2017","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0705","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s40272-016-0188-y","article-title":"Improving outcomes in infantile spasms: Role of pharmacotherapy","volume":"18","author":"Iyer","year":"2016","journal-title":"Paediatric Drugs"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0710","doi-asserted-by":"crossref","first-page":"228","DOI":"10.4103\/0972-2327.173314","article-title":"Infantile spasms: A prognostic evaluation","volume":"19","author":"Iype","year":"2016","journal-title":"Annals of Indian Academy of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0715","article-title":"Infantile spasms: An update on pre-clinical models and EEG mechanisms","volume":"7","author":"Janicot","year":"2020","journal-title":"Children (Basel)"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0720","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/ana.24631","article-title":"Epileptic encephalopathy de novo GABRB mutations impair gamma-aminobutyric acid type A receptor function","volume":"79","author":"Janve","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0725","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/j.1528-1157.1973.tb03952.x","article-title":"Long-term prognosis of 150 cases of \"West syndrome\"","volume":"14","author":"Jeavons","year":"1973","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0730","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0387-7604(87)80106-7","article-title":"Neuropathological aspects of infantile spasms","volume":"9","author":"Jellinger","year":"1987","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0735","unstructured":"Jensen, F. E. (2014). Combination therapies: Inhibitors of GABA transaminase and NKCC1. In USPTO (Ed.), Google Patents (Vol. US8822539B2). United States: Children's Medical Center Corp."},{"key":"10.1016\/j.pharmthera.2020.107578_bb0740","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.eplepsyres.2013.10.015","article-title":"Efficacy and tolerability of the galanin analog NAX 5055 in the multiple-hit rat model of symptomatic infantile spasms","volume":"108","author":"Jequier Gygax","year":"2014","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0745","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1111\/j.1471-4159.1980.tb11223.x","article-title":"Ontogeny of neurochemical markers for noradrenergic, GABAergic, and cholinergic neurons in neocortex lesioned with methylazoxymethanol acetate","volume":"34","author":"Johnston","year":"1980","journal-title":"Journal of Neurochemistry"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0750","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0074-7742(02)49005-8","article-title":"Hypotheses from functional neuroimaging studies","volume":"49","author":"Juhasz","year":"2002","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0755","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/j.1528-1157.1999.tb02006.x","article-title":"Age-specific N-methyl-D-aspartate-induced seizures: Perspectives for the West syndrome model","volume":"40","author":"K\u00e1bov\u00e1","year":"1999","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0760","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/exnr.1999.7318","article-title":"Prenatal methotrexate exposure decreases seizure susceptibility in young rats of two strains","volume":"161","author":"K\u00e1bov\u00e1","year":"2000","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0765","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1113\/jphysiol.2006.105254","article-title":"Fetal programming of hypothalamo-pituitary-adrenal function: Prenatal stress and glucocorticoids","volume":"572","author":"Kapoor","year":"2006","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0770","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1113\/jphysiol.2005.090191","article-title":"Short periods of prenatal stress affect growth, behaviour and hypothalamo-pituitary-adrenal axis activity in male Guinea pig offspring","volume":"566","author":"Kapoor","year":"2005","journal-title":"The Journal of Physiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0775","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.seizure.2008.09.006","article-title":"A retrospective study on aetiology based outcome of infantile spasms","volume":"18","author":"Karvelas","year":"2009","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0780","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/jhg.2017.53","article-title":"A novel missense mutation in the HECT domain of NEDD4L identified in a girl with periventricular nodular heterotopia, polymicrogyria and cleft palate","volume":"62","author":"Kato","year":"2017","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0785","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fnins.2015.00181","article-title":"Genotype-phenotype correlation in neuronal migration disorders and cortical dysplasias","volume":"9","author":"Kato","year":"2015","journal-title":"Frontiers in Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0790","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1212\/01.WNL.0000068012.69928.92","article-title":"Polyalanine expansion of ARX associated with cryptogenic West syndrome","volume":"61","author":"Kato","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0795","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1177\/08830738050200042001","article-title":"X-linked lissencephaly with abnormal genitalia as a tangential migration disorder causing intractable epilepsy: Proposal for a new term, \"interneuronopathy\"","volume":"20","author":"Kato","year":"2005","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0800","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1111\/j.1528-1167.2010.02559.x","article-title":"Frameshift mutations of the ARX gene in familial Ohtahara syndrome","volume":"51","author":"Kato","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0805","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1086\/518903","article-title":"A longer polyalanine expansion mutation in the ARX gene causes early infantile epileptic encephalopathy with suppression-burst pattern (Ohtahara syndrome)","volume":"81","author":"Kato","year":"2007","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0810","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1212\/WNL.0000000000000389","article-title":"PIGA mutations cause early-onset epileptic encephalopathies and distinctive features","volume":"82","author":"Kato","year":"2014","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0815","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/epi4.12280","article-title":"Acquired parvalbumin-selective interneuronopathy in the multiple-hit model of infantile spasms: A putative basis for the partial responsiveness to vigabatrin analogs?","volume":"3","author":"Katsarou","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0820","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.pediatrneurol.2013.11.021","article-title":"Ketogenic diet efficacy in the treatment of intractable epileptic spasms","volume":"50","author":"Kayyali","year":"2014","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0825","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11910-018-0832-8","article-title":"Infantile spasms-have we made progress?","volume":"18","author":"Kelley","year":"2018","journal-title":"Current Neurology and Neuroscience Reports"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0830","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.beem.2007.07.008","article-title":"Adrenal gland development and defects","volume":"22","author":"Kempna","year":"2008","journal-title":"Best Practice & Research. Clinical Endocrinology & Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0835","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1528-1167.2006.00835.x","article-title":"Hypothalamic hamartoma and infantile spasms","volume":"48","author":"Kerrigan","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0840","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3389\/fneur.2017.00271","article-title":"A new rat model of epileptic spasms based on methylazoxymethanol-induced malformations of cortical development","volume":"8","author":"Kim","year":"2017","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0845","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.braindev.2016.09.009","article-title":"A case of early onset epileptic encephalopathy with de novo mutation in SLC35A2: Clinical features and treatment for epilepsy","volume":"39","author":"Kimizu","year":"2017","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0850","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1046\/j.1365-2826.1998.00180.x","article-title":"Different developmental patterns of melanocortin MC3 and MC4 receptor mRNA: Predominance of Mc4 in fetal rat nervous system","volume":"10","author":"Kistler-Heer","year":"1998","journal-title":"Journal of Neuroendocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0855","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/ng1009","article-title":"Mutation of ARX causes abnormal development of forebrain and testes in mice and X-linked lissencephaly with abnormal genitalia in humans","volume":"32","author":"Kitamura","year":"2002","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0860","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.0013-9580.2004.30503.x","article-title":"Long-term cognitive outcomes of a cohort of children with cryptogenic infantile spasms treated with high-dose adrenocorticotropic hormone","volume":"45","author":"Kivity","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0865","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1002\/ana.24594","article-title":"Response to treatment in a prospective national infantile spasms cohort","volume":"79","author":"Knupp","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0870","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1111\/epi.13557","article-title":"Response to second treatment after initial failed treatment in a multicenter prospective infantile spasms cohort","volume":"57","author":"Knupp","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0875","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.devbrainres.2004.05.001","article-title":"Neural and hormonal consequences of neonatal 5,7-dihydroxytryptamine may not be associated with serotonin depletion","volume":"151","author":"Knuth","year":"2004","journal-title":"Brain Research. Developmental Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0880","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.eplepsyres.2018.06.013","article-title":"Vigabatrin and high-dose prednisolone therapy for patients with West syndrome","volume":"145","author":"Ko","year":"2018","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0885","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.eplepsyres.2018.02.003","article-title":"Targeted gene panel and genotype-phenotype correlation in children with developmental and epileptic encephalopathy","volume":"141","author":"Ko","year":"2018","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0890","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/epi.13344","article-title":"De novo GABRA1 mutations in Ohtahara and West syndromes","volume":"57","author":"Kodera","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0895","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1002\/dvg.20607","article-title":"Zebrafish gene knockdowns imply roles for human YWHAG in infantile spasms and cardiomegaly","volume":"48","author":"Komoike","year":"2010","journal-title":"Genesis"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0900","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1212\/WNL.43.11.2322","article-title":"Infantile spasms: Outcome and prognostic factors of cryptogenic and symptomatic groups","volume":"43","author":"Koo","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0905","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejphar.2007.11.066","article-title":"The central corticotropin releasing factor system during development and adulthood","volume":"583","author":"Korosi","year":"2008","journal-title":"European Journal of Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0910","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.yebeh.2009.01.023","article-title":"High-dose oral prednisolone for infantile spasms: An effective and less expensive alternative to ACTH","volume":"14","author":"Kossoff","year":"2009","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0915","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1046\/j.1528-1157.2002.11302.x","article-title":"Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet","volume":"43","author":"Kossoff","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0920","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1542\/peds.109.5.780","article-title":"Efficacy of the ketogenic diet for infantile spasms","volume":"109","author":"Kossoff","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0925","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/epi4.12225","article-title":"Optimal clinical management of children receiving dietary therapies for epilepsy: Updated recommendations of the international Ketogenic Diet Study Group","volume":"3","author":"Kossoff","year":"2018","journal-title":"Epilepsia Open"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0930","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1002\/ana.23960","article-title":"Everolimus treatment of refractory epilepsy in tuberous sclerosis complex","volume":"74","author":"Krueger","year":"2013","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0935","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awq238","article-title":"Phospholipase C beta 1 deficiency is associated with early-onset epileptic encephalopathy","volume":"133","author":"Kurian","year":"2010","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0940","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3345\/kjp.2018.61.5.150","article-title":"Long-term prenatal stress increases susceptibility of N-methyl-D-aspartic acid-induced spasms in infant rats","volume":"61","author":"Kwon","year":"2018","journal-title":"Korean Journal of Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0945","first-page":"529","article-title":"Calpain-2 as a treatment target in prenatal stress-induced epileptic spasms in infant rats","volume":"28","author":"Kwon","year":"2019","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0950","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.seizure.2010.01.008","article-title":"Treatment and long term outcome in West syndrome: The clinical reality. A multicentre follow up study","volume":"19","author":"Lagae","year":"2010","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0955","series-title":"American Epilepsy Society Annual Meeting (pp. C04). Seattle, WA","article-title":"(1\u20133)insulin-like growth factor 1 suppresses seizures and hypsarrhythmia in an animal model of infantile spasms","author":"Lee","year":"2014"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0960","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1111\/j.1528-1167.2007.01377.x","article-title":"A new animal model of infantile spasms with unprovoked persistent seizures","volume":"49","author":"Lee","year":"2008","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0965","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.braindev.2013.06.014","article-title":"Prognostic factors of infantile spasms: Role of treatment options including a ketogenic diet","volume":"35","author":"Lee","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0970","doi-asserted-by":"crossref","DOI":"10.1111\/ejn.14539","article-title":"How can methylprednisolone work on epileptic spasms with malformation of cortical development?","author":"Lee","year":"2019","journal-title":"The European Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0975","doi-asserted-by":"crossref","first-page":"248","DOI":"10.3389\/fneur.2018.00248","article-title":"In vivo multimodal magnetic resonance imaging changes after N-Methyl-d-Aspartate-triggered spasms in infant rats","volume":"9","author":"Lee","year":"2018","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0980","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1212\/WNL.0000000000002740","article-title":"Delineating the GRIN1 phenotypic spectrum: A distinct genetic NMDA receptor encephalopathy","volume":"86","author":"Lemke","year":"2016","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0985","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/ana.24073","article-title":"GRIN2B mutations in West syndrome and intellectual disability with focal epilepsy","volume":"75","author":"Lemke","year":"2014","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0990","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1002\/ajmg.a.31531","article-title":"A novel missense mutation in the NDP gene in a child with Norrie disease and severe neurological involvement including infantile spasms","volume":"143A","author":"Lev","year":"2007","journal-title":"American Journal of Medical Genetics. Part A"},{"key":"10.1016\/j.pharmthera.2020.107578_bb0995","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/jat.1007","article-title":"Pyridoxine (vitamin B6) neurotoxicity: Enhancement by protein-deficient diet","volume":"24","author":"Levine","year":"2004","journal-title":"Journal of Applied Toxicology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1000","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1016\/j.ajhg.2016.07.013","article-title":"GRIN2D recurrent de novo dominant mutation causes a severe epileptic encephalopathy treatable with NMDA receptor channel blockers","volume":"99","author":"Li","year":"2016","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1005","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1007\/s12035-017-0483-9","article-title":"Identification of de novo DNMT3A mutations that cause West syndrome by using whole-exome sequencing","volume":"55","author":"Liu","year":"2018","journal-title":"Molecular Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1010","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/B978-0-444-54299-1.00006-6","article-title":"Neurological phenotypes for down syndrome across the life span","volume":"197","author":"Lott","year":"2012","journal-title":"Progress in Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1015","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1073\/pnas.92.3.836","article-title":"Cloning and characterization of a functionally distinct corticotropin-releasing factor receptor subtype from rat brain","volume":"92","author":"Lovenberg","year":"1995","journal-title":"Proceedings of the National Academy of Sciences of the United States of America"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1020","doi-asserted-by":"crossref","first-page":"4563","DOI":"10.1038\/ncomms5563","article-title":"Selective suppression of excessive GluN2C expression rescues early epilepsy in a tuberous sclerosis murine model","volume":"5","author":"Lozovaya","year":"2014","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1025","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(04)17400-X","article-title":"The United Kingdom Infantile Spasms Study comparing vigabatrin with prednisolone or tetracosactide at 14\u202fdays: A multicentre, randomised controlled trial","volume":"364","author":"Lux","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1030","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S1474-4422(05)70199-X","article-title":"The United Kingdom Infantile Spasms Study (UKISS) comparing hormone treatment with vigabatrin on developmental and epilepsy outcomes to age 14\u202fmonths: A multicentre randomised trial","volume":"4","author":"Lux","year":"2005","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1035","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.0013-9580.2004.02404.x","article-title":"A proposal for case definitions and outcome measures in studies of infantile spasms and West syndrome: Consensus statement of the West Delphi group","volume":"45","author":"Lux","year":"2004","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1040","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1212\/01.WNL.0000127773.72699.C8","article-title":"Practice parameter: Medical treatment of infantile spasms: Report of the American Academy of Neurology and the Child Neurology Society","volume":"62","author":"Mackay","year":"2004","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1045","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/0165-3806(92)90178-Y","article-title":"N-methyl-D-aspartate (NMDA)-induced seizures in developing rats","volume":"65","author":"Mare\u0161","year":"1992","journal-title":"Brain Research. Developmental Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1050","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/brain\/awp107","article-title":"Targeted loss of Arx results in a developmental epilepsy mouse model and recapitulates the human phenotype in heterozygous females","volume":"132","author":"Marsh","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1055","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1242\/dmm.001883","article-title":"Developing an animal model for infantile spasms: Pathogenesis, problems and progress","volume":"2","author":"Marsh","year":"2009","journal-title":"Disease Models & Mechanisms"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12868-016-0265-8","article-title":"Developmental interneuron subtype deficits after targeted loss of Arx","volume":"17","author":"Marsh","year":"2016","journal-title":"BMC Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1065","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.ajhg.2008.06.001","article-title":"Infantile spasms is associated with deletion of the MAGI2 gene on chromosome 7q11.23-q21.11","volume":"83","author":"Marshall","year":"2008","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1070","doi-asserted-by":"crossref","first-page":"20c","DOI":"10.1042\/bj0980020C","article-title":"Studies on methylazoxymethanol, the aglycone of cycasin: Methylation of nucleic acids in vitro","volume":"98","author":"Matsumoto","year":"1966","journal-title":"The Biochemical Journal"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1075","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/en.2017-00896","article-title":"Prenatal stress, glucocorticoids, and developmental programming of the stress response","volume":"159","author":"McGowan","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1080","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2008-1052545","article-title":"Morphological aspects of aetiology and the course of infantile spasms (West-syndrome)","volume":"16","author":"Meencke","year":"1985","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1085","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1080\/13543784.2017.1323868","article-title":"Why do trials for Alzheimer's disease drugs keep failing? A discontinued drug perspective for 2010-2015","volume":"26","author":"Mehta","year":"2017","journal-title":"Expert Opinion on Investigational Drugs"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1090","doi-asserted-by":"crossref","first-page":"5422","DOI":"10.1523\/JNEUROSCI.0955-08.2008","article-title":"Response of a neuronal model of tuberous sclerosis to mammalian target of rapamycin (mTOR) inhibitors: Effects on mTORC1 and Akt signaling lead to improved survival and function","volume":"28","author":"Meikle","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1095","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1093\/hmg\/ddu199","article-title":"The genetic landscape of infantile spasms","volume":"23","author":"Michaud","year":"2014","journal-title":"Human Molecular Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1100","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1111\/epi.13601","article-title":"Infantile spasms and encephalopathy without preceding neonatal seizures caused by KCNQ2 R198Q, a gain-of-function variant","volume":"58","author":"Millichap","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1105","doi-asserted-by":"crossref","first-page":"64","DOI":"10.15844\/pedneurbriefs-29-8-7","article-title":"Hypsarhythmia or Hypsarrhythmia?","volume":"29","author":"Millichap","year":"2015","journal-title":"Pediatric Neurology Briefs"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1110","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1210\/en.2018-00732","article-title":"Neonatal estrogen causes irreversible male infertility via specific suppressive action on hypothalamic Kiss1 neurons","volume":"160","author":"Minabe","year":"2019","journal-title":"Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/jhg.2014.124","article-title":"Detecting copy-number variations in whole-exome sequencing data using the eXome Hidden Markov Model: An \u2018exome-first\u2019 approach","volume":"60","author":"Miyatake","year":"2015","journal-title":"Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1120","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.yebeh.2016.04.026","article-title":"White matter disruption is associated with persistent seizures in tuberous sclerosis complex","volume":"60","author":"Moavero","year":"2016","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1125","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1038\/ejhg.2015.176","article-title":"Reinitiation of mRNA translation in a patient with X-linked infantile spasms with a protein-truncating variant in ARX","volume":"24","author":"Moey","year":"2016","journal-title":"European Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1130","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1111\/j.1528-1167.2010.02963.x","article-title":"Seizure outcome in infantile spasms\u2014a retrospective study","volume":"52","author":"Mohamed","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1135","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1038\/mp.2014.61","article-title":"Adenomatous polyposis coli protein deletion leads to cognitive and autism-like disabilities","volume":"19","author":"Mohn","year":"2014","journal-title":"Molecular Psychiatry"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1140","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1046\/j.1528-1157.2003.34703.x","article-title":"Infantile spasms in a patient with Williams syndrome and craniosynostosis","volume":"44","author":"Morimoto","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1145","series-title":"American Epilepsy Society Annual Meeting (pp. 3.361). New Orleans, LA","article-title":"The ketogenic diet alters the gut microbiome in the triple-hit rodent model of infantile spasms","author":"Mu","year":"2018"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1150","doi-asserted-by":"crossref","first-page":"106181","DOI":"10.1016\/j.eplepsyres.2019.106181","article-title":"Genetic heterogeneity in infantile spasms","volume":"156","author":"Muir","year":"2019","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1155","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1177\/0883073808324535","article-title":"Rapamycin reduces seizure frequency in tuberous sclerosis complex","volume":"24","author":"Muncy","year":"2009","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1160","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.pediatrneurol.2018.11.007","article-title":"PLCB1 biallelic point mutations cause West syndrome","volume":"91","author":"Myers","year":"2019","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1165","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.eplepsyres.2015.07.008","article-title":"Improving the inter-rater agreement of hypsarrhythmia using a simplified EEG grading scale for children with infantile spasms","volume":"116","author":"Mytinger","year":"2015","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1170","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1007\/s007020170081","article-title":"Decreased cerebrospinal fluid levels of beta-endorphin and ACTH in children with infantile spasms","volume":"108","author":"Nagamitsu","year":"2001","journal-title":"Journal of Neural Transmission"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1175","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.1111\/epi.13257","article-title":"De novo DNM1 mutations in two cases of epileptic encephalopathy","volume":"57","author":"Nakashima","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1180","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1111\/j.1528-1157.1985.tb05678.x","article-title":"Reduced ACTH content in cerebrospinal fluid of children affected by cryptogenic infantile spasms with hypsarrhythmia","volume":"26","author":"Nalin","year":"1985","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1185","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nn.2647","article-title":"Animal models of neuropsychiatric disorders","volume":"13","author":"Nestler","year":"2010","journal-title":"Nature Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1190","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.braindev.2012.05.002","article-title":"Progressive diffuse brain atrophy in West syndrome with marked hypomyelination due to SPTAN1 gene mutation","volume":"35","author":"Nonoda","year":"2013","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1195","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1002\/cne.21162","article-title":"Ontogeny of hippocampal corticosteroid receptors: Effects of antenatal glucocorticoids in human and mouse","volume":"499","author":"Noorlander","year":"2006","journal-title":"The Journal of Comparative Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1200","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1542\/peds.108.1.129","article-title":"Experience with the ketogenic diet in infants","volume":"108","author":"Nordli","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1205","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2352-4642(18)30244-X","article-title":"Vigabatrin with hormonal treatment versus hormonal treatment alone (ICISS) for infantile spasms: 18-month outcomes of an open-label, randomised controlled trial","volume":"2","author":"O'Callaghan","year":"2018","journal-title":"The Lancet Child & Adolescent Health"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1210","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S1474-4422(16)30294-0","article-title":"Safety and effectiveness of hormonal treatment versus hormonal treatment with vigabatrin for infantile spasms (ICISS): A randomised, multicentre, open-label trial","volume":"16","author":"O'Callaghan","year":"2017","journal-title":"Lancet Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1215","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1111\/j.1528-1167.2011.03127.x","article-title":"The effect of lead time to treatment and of age of onset on developmental outcome at 4\u202fyears in infantile spasms: Evidence from the United Kingdom Infantile Spasms Study","volume":"52","author":"O'Callaghan","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1220","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.braindev.2008.11.007","article-title":"A pilot study on the changes in immunity after ACTH therapy in patients with West syndrome","volume":"31","author":"Ohya","year":"2009","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1225","series-title":"The physiology of reproduction","first-page":"363","article-title":"Puberty in the rat","volume":"Vol. 1","author":"Ojeda","year":"1994"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1230","doi-asserted-by":"crossref","first-page":"220ra212","DOI":"10.1126\/scitranslmed.3007231","article-title":"Neonatal estradiol stimulation prevents epilepsy in Arx model of X-linked infantile spasms syndrome","volume":"6","author":"Olivetti","year":"2014","journal-title":"Science Translational Medicine"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1235","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1111\/j.1528-1167.2011.03173.x","article-title":"Carisbamate acutely suppresses spasms in a rat model of symptomatic infantile spasms","volume":"52","author":"Ono","year":"2011","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1240","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1111\/epi.16305","article-title":"The underlying etiology of infantile spasms (West syndrome): Information from the International Collaborative Infantile Spasms Study (ICISS)","volume":"60","author":"Osborne","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1245","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1111\/j.1528-1167.2010.02695.x","article-title":"The underlying etiology of infantile spasms (West syndrome): Information from the United Kingdom Infantile Spasms Study (UKISS) on contemporary causes and their classification","volume":"51","author":"Osborne","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1250","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/jcph.1309","article-title":"Proposition of a minimal effective dose of vigabatrin for the treatment of infantile spasms using pediatric and adult pharmacokinetic data","volume":"59","author":"Ounissi","year":"2019","journal-title":"Journal of Clinical Pharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1255","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1212\/WNL.0b013e31822e5627","article-title":"Massive expansion of SCA2 with autonomic dysfunction, retinitis pigmentosa, and infantile spasms","volume":"77","author":"Paciorkowski","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1260","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.pediatrneurol.2011.08.010","article-title":"Genetic and biologic classification of infantile spasms","volume":"45","author":"Paciorkowski","year":"2011","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1265","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10048-013-0356-y","article-title":"MEF2C Haploinsufficiency features consistent hyperkinesis, variable epilepsy, and has a role in dorsal and ventral neuronal developmental pathways","volume":"14","author":"Paciorkowski","year":"2013","journal-title":"Neurogenetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1270","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1684\/epd.2012.0546","article-title":"Eating-induced epileptic spasms in a boy with MECP2 duplication syndrome: Insights into pathogenesis of genetic epilepsies","volume":"14","author":"de Palma","year":"2012","journal-title":"Epileptic Disorders"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1275","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1111\/dmcn.12976","article-title":"GABRB3 mutations: A new and emerging cause of early infantile epileptic encephalopathy","volume":"58","author":"Papandreou","year":"2016","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1280","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1208\/s12248-018-0204-y","article-title":"Why drugs fail in late stages of development: Case study analyses from the last decade and recommendations","volume":"20","author":"Parasrampuria","year":"2018","journal-title":"The AAPS Journal"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1285","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1177\/0883073807310988","article-title":"Major adverse events associated with treatment of infantile spasms","volume":"22","author":"Partikian","year":"2007","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1290","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1136\/adc.55.11.870","article-title":"Infantile spasms syndrome in monozygotic twins","volume":"55","author":"Pavone","year":"1980","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1295","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.braindev.2013.10.008","article-title":"Infantile spasms syndrome, West syndrome and related phenotypes: What we know in 2013","volume":"36","author":"Pavone","year":"2014","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1300","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.1111\/epi.14032","article-title":"White matter spongiosis with vigabatrin therapy for infantile spasms","volume":"59","author":"Pearl","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1305","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1111\/j.1528-1167.2008.01728.x","article-title":"Cerebral MRI abnormalities associated with vigabatrin therapy","volume":"50","author":"Pearl","year":"2009","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1310","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1111\/j.1528-1167.2010.02657.x","article-title":"Infantile spasms: A U.S. consensus report","volume":"51","author":"Pellock","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1315","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.ajhg.2014.04.012","article-title":"Mutations in DOCK7 in individuals with epileptic encephalopathy and cortical blindness","volume":"94","author":"Perrault","year":"2014","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1320","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.eplepsyres.2019.03.001","article-title":"Identifying mutations in epilepsy genes: Impact on treatment selection","volume":"152","author":"Perucca","year":"2019","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1325","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.eplepsyres.2012.11.009","article-title":"Ketogenic diet for infantile spasms refractory to first-line treatments: An open prospective study","volume":"105","author":"Pires","year":"2013","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1330","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.nbd.2016.11.002","article-title":"APC conditional knock-out mouse is a model of infantile spasms with elevated neuronal beta-catenin levels, neonatal spasms, and chronic seizures","volume":"98","author":"Pirone","year":"2017","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1335","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3389\/fnsyn.2018.00035","article-title":"Social stimulus causes aberrant activation of the medial prefrontal cortex in a mouse model with autism-like behaviors","volume":"10","author":"Pirone","year":"2018","journal-title":"Frontiers in Synaptic Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1340","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1136\/jmedgenet-2016-104509","article-title":"GRIN2B encephalopathy: Novel findings on phenotype, variant clustering, functional consequences and treatment aspects","volume":"54","author":"Platzer","year":"2017","journal-title":"Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1345","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1177\/0883073818768309","article-title":"Vigabatrin for epileptic spasms and tonic seizures in tuberous sclerosis complex","volume":"33","author":"van der Poest Clement","year":"2018","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1350","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.eplepsyres.2008.03.019","article-title":"Combination of infantile spasms, non-epileptic seizures and complex movement disorder: A new case of ARX-related epilepsy","volume":"80","author":"Poirier","year":"2008","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1355","doi-asserted-by":"crossref","first-page":"e121","DOI":"10.1111\/epi.16372","article-title":"The epileptology of GNB5 encephalopathy","volume":"60","author":"Poke","year":"2019","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1360","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/humu.20935","article-title":"Mutational, functional, and expression studies of the TCF4 gene in Pitt-Hopkins syndrome","volume":"30","author":"de Pontual","year":"2009","journal-title":"Human Mutation"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1365","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.yebeh.2013.08.037","article-title":"Report of a parent survey of cannabidiol-enriched cannabis use in pediatric treatment-resistant epilepsy","volume":"29","author":"Porter","year":"2013","journal-title":"Epilepsy & Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1370","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/ane.12830","article-title":"Efficacy of ketogenic diet for infantile spasms: A systematic review","volume":"137","author":"Prezioso","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1375","doi-asserted-by":"crossref","first-page":"8752","DOI":"10.1523\/JNEUROSCI.0915-09.2009","article-title":"A triplet repeat expansion genetic mouse model of infantile spasms syndrome, Arx(GCG)10+7, with interneuronopathy, spasms in infancy, persistent seizures, and adult cognitive and behavioral impairment","volume":"29","author":"Price","year":"2009","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1380","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.nbd.2011.03.021","article-title":"A pulse rapamycin therapy for infantile spasms and associated cognitive decline","volume":"43","author":"Raffo","year":"2011","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1385","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1111\/j.1528-1167.2012.03499.x","article-title":"Diurnal and sleep\/wake patterns of epileptic spasms in different age groups","volume":"53","author":"Ramgopal","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1390","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/088307380001500409","article-title":"Familial idiopathic West syndrome","volume":"15","author":"Reiter","year":"2000","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1395","doi-asserted-by":"crossref","DOI":"10.1111\/epi.16495","article-title":"Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex","author":"Rensing","year":"2020","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1400","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-2008-1059590","article-title":"A long-term follow-up study of 214 children with the syndrome of infantile spasms","volume":"13","author":"Riikonen","year":"1982","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1405","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1177\/088307380401900601","article-title":"Infantile spasms: Therapy and outcome","volume":"19","author":"Riikonen","year":"2004","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1410","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40263-014-0139-5","article-title":"Recent advances in the pharmacotherapy of infantile spasms","volume":"28","author":"Riikonen","year":"2014","journal-title":"CNS Drugs"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1415","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1111\/epi.12953","article-title":"Long-term outcome in children with infantile spasms treated with vigabatrin: A cohort of 180 patients","volume":"56","author":"Riikonen","year":"2015","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1420","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1469-8749.1979.tb01625.x","article-title":"Incidence and aetiology of infantile spasms from 1960 to 1976: A population study in Finland","volume":"21","author":"Riikonen","year":"1979","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1425","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1136\/adc.55.9.664","article-title":"ACTH therapy in infantile spasms: Side effects","volume":"55","author":"Riikonen","year":"1980","journal-title":"Archives of Disease in Childhood"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1430","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/dmcn.12573","article-title":"Does vigabatrin treatment for infantile spasms cause visual field defects? An international multicentre study","volume":"57","author":"Riikonen","year":"2015","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1435","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ejpn.2015.11.005","article-title":"Infantile spasms and 15q11.2q13.1 chromosome duplication in two successive generations","volume":"20","author":"Riikonen","year":"2016","journal-title":"European Journal of Paediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1440","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1096-8628(19990312)83:2<132::AID-AJMG9>3.0.CO;2-Y","article-title":"Evidence for a new X-linked mental retardation gene in Xp21-Xp22: Clinical and molecular data in one family","volume":"83","author":"Ronce","year":"1999","journal-title":"American Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1445","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00381-008-0706-5","article-title":"Neurofibromatosis type 1 and infantile spasms","volume":"25","author":"Ruggieri","year":"2009","journal-title":"Child's Nervous System"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1450","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/mrdd.20164","article-title":"Using mouse models to explore genotype-phenotype relationship in Down syndrome","volume":"13","author":"Salehi","year":"2007","journal-title":"Mental Retardation and Developmental Disabilities Research Reviews"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1455","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1111\/epi.14529","article-title":"Everolimus in infants with tuberous sclerosis complex-related West syndrome: First results from a single-center prospective observational study","volume":"59","author":"Samueli","year":"2018","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1460","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.nbd.2009.11.011","article-title":"A model of symptomatic infantile spasms syndrome","volume":"37","author":"Scantlebury","year":"2010","journal-title":"Neurobiology of Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1465","series-title":"Model of infantile spasm syndrome","volume":"Vol. US7863499B2","author":"Scantlebury","year":"2011"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1470","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJM198308253090801","article-title":"Sensory neuropathy from pyridoxine abuse. A new megavitamin syndrome","volume":"309","author":"Schaumburg","year":"1983","journal-title":"The New England Journal of Medicine"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1475","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/epi.13709","article-title":"ILAE classification of the epilepsies: Position paper of the ILAE Commission for Classification and Terminology","volume":"58","author":"Scheffer","year":"2017","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1480","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1212\/WNL.59.3.348","article-title":"X-linked myoclonic epilepsy with spasticity and intellectual disability: Mutation in the homeobox gene ARX","volume":"59","author":"Scheffer","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1485","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1111\/epi.12648","article-title":"Epilepsy and outcome in FOXG1-related disorders","volume":"55","author":"Seltzer","year":"2014","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1490","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pediatrneurol.2009.09.003","article-title":"Association between prenatal stress and infantile spasms: A case-control study in China","volume":"42","author":"Shang","year":"2010","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1495","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.spen.2016.06.002","article-title":"The expanding clinical spectrum of genetic pediatric epileptic encephalopathies","volume":"23","author":"Shbarou","year":"2016","journal-title":"Seminars in Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1500","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1097\/00008480-200312000-00004","article-title":"The ARX story (epilepsy, mental retardation, autism, and cerebral malformations): One gene leads to many phenotypes","volume":"15","author":"Sherr","year":"2003","journal-title":"Current Opinion in Pediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1505","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.lfs.2016.03.047","article-title":"Increased precipitation of spasms in an animal model of infantile spasms by prenatal stress exposure","volume":"152","author":"Shi","year":"2016","journal-title":"Life Sciences"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1510","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.eplepsyres.2015.09.014","article-title":"Development of a mouse model of infantile spasms induced by N-methyl-D-aspartate","volume":"118","author":"Shi","year":"2015","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1515","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.neuropharm.2018.01.011","article-title":"Do ketone bodies mediate the anti-seizure effects of the ketogenic diet?","volume":"133","author":"Simeone","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1520","first-page":"538","article-title":"Quantitative characteristics of hypsarrhythmia in infantile spasms","volume":"2018","author":"Smith","year":"2018","journal-title":"Conference Proceedings: Annual International Conference of the IEEE Engineering in Medicine and Biology Society"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1525","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1007\/s10548-017-0588-5","article-title":"Long-range temporal correlations reflect treatment response in the electroencephalogram of patients with infantile spasms","volume":"30","author":"Smith","year":"2017","journal-title":"Brain Topography"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1530","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.33.8.966","article-title":"ACTH and prednisone in childhood seizure disorders","volume":"33","author":"Snead","year":"1983","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1535","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1212\/WNL.39.8.1027","article-title":"Treatment of infantile spasms with high-dose ACTH: Efficacy and plasma levels of ACTH and cortisol","volume":"39","author":"Snead","year":"1989","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1540","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1177\/088307389200700114","article-title":"GABA and epilepsy: Their complex relationship and the evolution of our understanding","volume":"7","author":"Snodgrass","year":"1992","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1545","doi-asserted-by":"crossref","first-page":"3309","DOI":"10.1523\/JNEUROSCI.3850-05.2006","article-title":"Maternal stress produces learning deficits associated with impairment of NMDA receptor-mediated synaptic plasticity","volume":"26","author":"Son","year":"2006","journal-title":"The Journal of Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1550","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/WNF.0000000000000200","article-title":"Efficacy of treatments for infantile spasms: A systematic review","volume":"40","author":"Song","year":"2017","journal-title":"Clinical Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1555","first-page":"130","article-title":"A propos de 21 cas d'hypsarythmie de Gibbs. Son traitement spectaculaire par l'ACTH","volume":"58","author":"Sorel","year":"1958","journal-title":"Acta Neurologica Belgica"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1560","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1528-1167.2009.02318.x","article-title":"Carisbamate as adjunctive treatment of partial onset seizures in adults in two randomized, placebo-controlled trials","volume":"51","author":"Sperling","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1565","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1212\/WNL.0000000000004152","article-title":"DNM1 encephalopathy: A new disease of vesicle fission","volume":"89","author":"von Spiczak","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1570","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1177\/0883073811413129","article-title":"Treatment of infantile spasms: Emerging insights from clinical and basic science perspectives","volume":"26","author":"Stafstrom","year":"2011","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1575","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0074-7742(02)49023-X","article-title":"Infantile spasms: Criteria for an animal model","volume":"49","author":"Stafstrom","year":"2002","journal-title":"International Review of Neurobiology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1580","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1111\/j.1469-8749.1994.tb11894.x","article-title":"Infantile spasms in children with down syndrome","volume":"36","author":"Stafstrom","year":"1994","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1585","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1111\/j.1528-1167.2006.00674_1.x","article-title":"Models of pediatric epilepsies: Strategies and opportunities","volume":"47","author":"Stafstrom","year":"2006","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1590","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S0920-1211(02)00258-9","article-title":"NMDA-induced seizures in developing rats cause long-term learning impairment and increased seizure susceptibility","volume":"53","author":"Stafstrom","year":"2003","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1595","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ymgme.2011.05.014","article-title":"Pyridoxine dependent epilepsy and antiquitin deficiency: Clinical and molecular characteristics and recommendations for diagnosis, treatment and follow-up","volume":"104","author":"Stockler","year":"2011","journal-title":"Molecular Genetics and Metabolism"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1600","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/ng862","article-title":"Mutations in the human ortholog of Aristaless cause X-linked mental retardation and epilepsy","volume":"30","author":"Stromme","year":"2002","journal-title":"Nature Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1605","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/j.1469-8749.2011.04096.x","article-title":"Immune-mediated steroid-responsive epileptic spasms and epileptic encephalopathy associated with VGKC-complex antibodies","volume":"53","author":"Suleiman","year":"2011","journal-title":"Developmental Medicine and Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1610","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1097\/NEN.0000000000000048","article-title":"Arx is required for specification of the zona incerta and reticular nucleus of the thalamus","volume":"73","author":"Sunnen","year":"2014","journal-title":"Journal of Neuropathology and Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1615","series-title":"Brain development and epilepsy","first-page":"195","article-title":"Synaptogenesis and epileptogenesis in developing neural networks","author":"Swann","year":"1995"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1620","series-title":"American Epilepsy Society Annual Meeting (pp. 1.023). Washington, DC","article-title":"Infantile spasms: ACTH dose response relationships","author":"Swann","year":"2017"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1625","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1038\/s41467-019-10482-9","article-title":"Comprehensive analysis of coding variants highlights genetic complexity in developmental and epileptic encephalopathy","volume":"10","author":"Takata","year":"2019","journal-title":"Nature Communications"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1630","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ejmg.2015.05.006","article-title":"Progressive brain atrophy in Schinzel-Giedion syndrome with a SETBP1 mutation","volume":"58","author":"Takeuchi","year":"2015","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1635","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.seizure.2017.03.004","article-title":"Breaking the cycle: A comparison between intravenous immunoglobulins and high dosage prednisone in the treatment of medically intractable epilepsy in children","volume":"47","author":"Tang-Wai","year":"2017","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1640","doi-asserted-by":"crossref","first-page":"xxiii","DOI":"10.1677\/joe.0.0090334","article-title":"The estimation of ACTH in human pituitary tissue","volume":"9","author":"Taylor","year":"1953","journal-title":"The Journal of Endocrinology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1645","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/j.0013-9580.2005.53304.x","article-title":"Can you predict an immediate, complete, and sustained response to the ketogenic diet?","volume":"46","author":"Than","year":"2005","journal-title":"Epilepsia"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2020.107578_bb1650","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1046\/j.1528-1157.43.s.3.11.x","article-title":"Neonatal seizures and syndromes","volume":"43","author":"Tharp","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1655","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/bdr2.1183","article-title":"Widespread dynamic and pleiotropic expression of the melanocortin-1-receptor (MC1R) system is conserved across chick, mouse and human embryonic development","volume":"110","author":"Thomas","year":"2018","journal-title":"Birth Defects Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1660","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1528-1157.1987.tb03615.x","article-title":"Failure of ACTH to alter transfer kindling in the immature brain","volume":"28","author":"Thompson","year":"1987","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1665","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/epi.13315","article-title":"Enhanced long-term potentiation in mature rats in a model of epileptic spasms with betamethasone-priming and postnatal N-methyl-d-aspartate administration","volume":"57","author":"Tsuji","year":"2016","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1670","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/0027-5107(72)90206-0","article-title":"The effect of methylazoxymethanol acetate on DNA synthesis and cell proliferation of synchronous HeLa cells","volume":"16","author":"Van den Berg","year":"1972","journal-title":"Mutation Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1675","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1046\/j.1528-1157.2002.17801.x","article-title":"Visual field constriction in 91 Finnish children treated with vigabatrin","volume":"43","author":"Vanhatalo","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1680","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1212\/WNL.52.8.1713","article-title":"Visual field constriction in children treated with vigabatrin","volume":"52","author":"Vanhatalo","year":"1999","journal-title":"Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1685","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.eplepsyres.2011.01.019","article-title":"Prenatal corticosteroid exposure alters early developmental seizures and behavior","volume":"95","author":"Vel\u00ed\u0161ek","year":"2011","journal-title":"Epilepsy Research"},{"issue":"Suppl. 3","key":"10.1016\/j.pharmthera.2020.107578_bb1690","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1528-1167.2010.02630.x","article-title":"Model of cryptogenic infantile spasms after prenatal corticosteroid priming","volume":"51","author":"Vel\u00ed\u0161ek","year":"2010","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1695","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/ana.21082","article-title":"Model of infantile spasms induced by N-methyl-d-aspartic acid in prenatally impaired brain","volume":"61","author":"Vel\u00ed\u0161ek","year":"2007","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1700","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/0091-3057(95)00115-D","article-title":"Age-dependent anticonvulsant action of clonazepam in the N-methyl-d-aspartate model of seizures","volume":"52","author":"Vel\u00ed\u0161ek","year":"1995","journal-title":"Pharmacology, Biochemistry, and Behavior"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1705","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0920-1211(97)00088-0","article-title":"Proconvulsant effects induced by pyridoxine in young rats","volume":"29","author":"Vere\u0161ov\u00e1","year":"1998","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1710","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0304-3940(84)90226-X","article-title":"Enhancement of spike and wave discharges by GABAmimetic drugs in rats with spontaneous petit-mal-like epilesy","volume":"27","author":"Vergnes","year":"1984","journal-title":"Neuroscience Letters"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1715","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/ane.13006","article-title":"Electroclinical features of epilepsy monosomy 1p36 syndrome and their implications","volume":"138","author":"Verrotti","year":"2018","journal-title":"Acta Neurologica Scandinavica"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1720","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.expneurol.2011.09.033","article-title":"Epilepsy and brain inflammation","volume":"244","author":"Vezzani","year":"2013","journal-title":"Experimental Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1725","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1111\/j.1528-1167.2005.00298.x","article-title":"Brain inflammation in epilepsy: Experimental and clinical evidence","volume":"46","author":"Vezzani","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1730","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/j.1528-1157.1997.tb00063.x","article-title":"Vigabatrin versus ACTH as first-line treatment for infantile spasms: A randomized, prospective study","volume":"38","author":"Vigevano","year":"1997","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1735","doi-asserted-by":"crossref","first-page":"605","DOI":"10.3389\/fgene.2019.00605","article-title":"De novo germline mutations in SEMA5A associated with infantile spasms","volume":"10","author":"Wang","year":"2019","journal-title":"Frontiers in Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1740","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1002\/ana.21058","article-title":"Neocortical hyperexcitability in a human case of tuberous sclerosis complex and mice lacking neuronal expression of TSC1","volume":"61","author":"Wang","year":"2007","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1745","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.pediatrneurol.2017.07.008","article-title":"Randomized, single-blind, parallel clinical trial on efficacy of oral prednisolone versus intramuscular corticotropin: A 12-month assessment of spasm control in West syndrome","volume":"76","author":"Wanigasinghe","year":"2017","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1750","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1086\/426462","article-title":"Mutations of CDKL5 cause a severe neurodevelopmental disorder with infantile spasms and mental retardation","volume":"75","author":"Weaving","year":"2004","journal-title":"American Journal of Human Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1755","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/10253890.2011.588294","article-title":"Sex-dependent changes induced by prenatal stress in cortical and hippocampal morphology and behaviour in rats: An update","volume":"14","author":"Weinstock","year":"2011","journal-title":"Stress"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1760","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ynstr.2016.08.004","article-title":"Prenatal stressors in rodents: Effects on behavior","volume":"6","author":"Weinstock","year":"2017","journal-title":"Neurobiology of Stress"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1765","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/S0140-6736(00)40184-4","article-title":"On a peculiar form of infantile convulsions","author":"West","year":"1841","journal-title":"Lancet"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1770","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.eplepsyres.2014.11.012","article-title":"Neurodevelopmental outcome of infantile spasms: A systematic review and meta-analysis","volume":"109","author":"Widjaja","year":"2015","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1775","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1006\/mcne.1998.0729","article-title":"Estrogen promotes the initial migration and inception of NgCAM-dependent calcium-signaling by new neurons of the adult songbird brain","volume":"13","author":"Williams","year":"1999","journal-title":"Molecular and Cellular Neurosciences"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1780","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1055\/s-2008-1059597","article-title":"Use of ACTH fragments of children with infantile spasms","volume":"13","author":"Willig","year":"1982","journal-title":"Neuropediatrics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1785","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1038\/nrn1954","article-title":"The origin and specification of cortical interneurons","volume":"7","author":"Wonders","year":"2006","journal-title":"Nature Reviews. Neuroscience"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1790","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/2319-4170.110365","article-title":"Mammalian target of rapamycin (mTOR) pathways in neurological diseases","volume":"36","author":"Wong","year":"2013","journal-title":"Biomedical Journal"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1795","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.ejmg.2012.10.011","article-title":"17q21.31 microdeletion associated with infantile spasms","volume":"56","author":"Wray","year":"2013","journal-title":"European Journal of Medical Genetics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1800","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.pediatrneurol.2010.04.005","article-title":"Effect of price increase of adrenocorticotropic hormone on treatment practices of infantile spasms","volume":"43","author":"Wray","year":"2010","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1805","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.bbr.2007.01.018","article-title":"Effect of varied gestational stress on acquisition of spatial memory, hippocampal LTP and synaptic proteins in juvenile male rats","volume":"179","author":"Yaka","year":"2007","journal-title":"Behavioural Brain Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1810","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/S0387-7604(01)00392-8","article-title":"Early-infantile epileptic encephalopathy with suppression-bursts, Ohtahara syndrome; its overview referring to our 16 cases","volume":"24","author":"Yamatogi","year":"2002","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1815","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3389\/fneur.2019.00050","article-title":"Transcranial direct current stimulation for patients with pharmacoresistant epileptic spasms: A pilot study","volume":"10","author":"Yang","year":"2019","journal-title":"Frontiers in Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1820","doi-asserted-by":"crossref","first-page":"2539","DOI":"10.3892\/mmr.2015.3751","article-title":"Association analysis of polymorphisms of the CRHR1 gene with infantile spasms","volume":"12","author":"Yang","year":"2015","journal-title":"Molecular Medicine Reports"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1825","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1111\/cns.12598","article-title":"Upregulations of CRH and CRHR1 in the epileptogenic tissues of patients with intractable infantile spasms","volume":"23","author":"Yang","year":"2017","journal-title":"CNS Neuroscience & Therapeutics"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1830","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.pediatrneurol.2017.03.017","article-title":"Short-term outcome of intravenous methylprednisolone pulse therapy in patients with infantile spasms","volume":"71","author":"Yeh","year":"2017","journal-title":"Pediatric Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1835","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1002\/ana.25032","article-title":"GABBR2 mutations determine phenotype in rett syndrome and epileptic encephalopathy","volume":"82","author":"Yoo","year":"2017","journal-title":"Annals of Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1840","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1016\/j.neuropharm.2004.07.031","article-title":"Multiple functions for the cadherin\/catenin complex during neuronal development","volume":"47","author":"Yu","year":"2004","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1845","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.seizure.2008.02.007","article-title":"Effect of a ketogenic diet on EEG: Analysis of sample entropy","volume":"17","author":"Yum","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1850","doi-asserted-by":"crossref","first-page":"e46","DOI":"10.1111\/j.1528-1167.2011.03357.x","article-title":"Prenatal stress promotes development of spasms in infant rats","volume":"53","author":"Yum","year":"2012","journal-title":"Epilepsia"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1855","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0883073812446485","article-title":"Vigabatrin and mental retardation in tuberous sclerosis: Infantile spasms versus focal seizures","volume":"28","author":"Yum","year":"2013","journal-title":"Journal of Child Neurology"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1860","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1016\/j.eplepsyres.2014.08.015","article-title":"A potential effect of ganaxolone in an animal model of infantile spasms","volume":"108","author":"Yum","year":"2014","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1865","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.eplepsyres.2015.08.005","article-title":"beta-Hydroxybutyrate attenuates NMDA-induced spasms in rats with evidence of neuronal stabilization on MR spectroscopy","volume":"117","author":"Yum","year":"2015","journal-title":"Epilepsy Research"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1870","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S0387-7604(96)00045-9","article-title":"Adrenocorticotropic hormone and vigabatrin treatment of children with infantile spasms underlying cerebral palsy","volume":"18","author":"Zafeiriou","year":"1996","journal-title":"Brain Dev"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1875","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s11011-019-0384-x","article-title":"Severe infantile epileptic encephalopathy associated with D-glyceric aciduria: Report of a novel case and review","volume":"34","author":"Zehavi","year":"2019","journal-title":"Metabolic Brain Disease"},{"key":"10.1016\/j.pharmthera.2020.107578_bb1880","doi-asserted-by":"crossref","DOI":"10.1111\/gbb.12456","article-title":"Novel mutations and phenotypes of epilepsy-associated genes in epileptic encephalopathies","volume":"17","author":"Zhou","year":"2018","journal-title":"Genes, Brain, and Behavior"}],"container-title":["Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0163725820301066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T22:05:29Z","timestamp":1759010729000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0163725820301066"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,8]]},"references-count":377,"alternative-id":["S0163725820301066"],"URL":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107578","relation":{},"ISSN":["0163-7258"],"issn-type":[{"value":"0163-7258","type":"print"}],"subject":[],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Modeling epileptic spasms during infancy: Are we heading for the treatment yet?","name":"articletitle","label":"Article Title"},{"value":"Pharmacology & Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pharmthera.2020.107578","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"107578"}}